These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 23670291

  • 1. Search for mutations in signaling pathways in head and neck squamous cell carcinoma.
    De Carvalho TG, De Carvalho AC, Maia DC, Ogawa JK, Carvalho AL, Vettore AL.
    Oncol Rep; 2013 Jul; 30(1):334-40. PubMed ID: 23670291
    [Abstract] [Full Text] [Related]

  • 2. Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.
    Suda T, Hama T, Kondo S, Yuza Y, Yoshikawa M, Urashima M, Kato T, Moriyama H.
    BMC Cancer; 2012 Sep 20; 12():416. PubMed ID: 22994622
    [Abstract] [Full Text] [Related]

  • 3. Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.
    Bruckman KC, Schönleben F, Qiu W, Woo VL, Su GH.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Nov 20; 110(5):632-7. PubMed ID: 20813562
    [Abstract] [Full Text] [Related]

  • 4. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
    Prigge ES, Urban K, Stiegler S, Müller M, Kloor M, Mai S, Ottstadt M, Lohr F, Wenz F, Wagner S, Wittekindt C, Klussmann JP, Hampl M, von Knebel Doeberitz M, Reuschenbach M.
    Hum Pathol; 2014 Nov 20; 45(11):2347-54. PubMed ID: 25257576
    [Abstract] [Full Text] [Related]

  • 5. Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.
    Chau NG, Li YY, Jo VY, Rabinowits G, Lorch JH, Tishler RB, Margalit DN, Schoenfeld JD, Annino DJ, Goguen LA, Thomas T, Becker H, Haddad T, Krane JF, Lindeman NI, Shapiro GI, Haddad RI, Hammerman PS.
    Clin Cancer Res; 2016 Jun 15; 22(12):2939-49. PubMed ID: 26763254
    [Abstract] [Full Text] [Related]

  • 6. Human papillomavirus and gene mutations in head and neck squamous carcinomas.
    Friedland P, Thomas A, Naran A, Amanuel B, Grieu-Iacopetta F, Carrello A, Harnett G, Meyer C, Phillips M.
    ANZ J Surg; 2012 May 15; 82(5):362-6. PubMed ID: 22507644
    [Abstract] [Full Text] [Related]

  • 7. KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC).
    Casadei Gardini A, Capelli L, Ulivi P, Giannini M, Freier E, Tamberi S, Scarpi E, Passardi A, Zoli W, Ragazzini A, Amadori D, Frassineti GL.
    PLoS One; 2014 May 15; 9(3):e92071. PubMed ID: 24642661
    [Abstract] [Full Text] [Related]

  • 8. Mutations of the BRAF gene in squamous cell carcinoma of the head and neck.
    Weber A, Langhanki L, Sommerer F, Markwarth A, Wittekind C, Tannapfel A.
    Oncogene; 2003 Jul 24; 22(30):4757-9. PubMed ID: 12879021
    [Abstract] [Full Text] [Related]

  • 9. Gene status of head and neck squamous cell carcinoma cell lines and cetuximab-mediated biological activities.
    Kondo N, Tsukuda M, Taguchi T, Nakazaki K, Sakakibara A, Takahashi H, Toth G, Nishimura G.
    Cancer Sci; 2011 Sep 24; 102(9):1717-23. PubMed ID: 21631644
    [Abstract] [Full Text] [Related]

  • 10. Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers.
    Lee SY, Kim MJ, Jin G, Yoo SS, Park JY, Choi JE, Jeon HS, Cho S, Lee EB, Cha SI, Park TI, Kim CH, Jung TH, Park JY.
    J Thorac Oncol; 2010 Nov 24; 5(11):1734-40. PubMed ID: 20881644
    [Abstract] [Full Text] [Related]

  • 11. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
    Tinhofer I, Budach V, Saki M, Konschak R, Niehr F, Jöhrens K, Weichert W, Linge A, Lohaus F, Krause M, Neumann K, Endris V, Sak A, Stuschke M, Balermpas P, Rödel C, Avlar M, Grosu AL, Abdollahi A, Debus J, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Baumann M, DKTK-ROG.
    Eur J Cancer; 2016 Apr 24; 57():78-86. PubMed ID: 26896955
    [Abstract] [Full Text] [Related]

  • 12. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
    Juanpere N, Agell L, Lorenzo M, de Muga S, López-Vilaró L, Murillo R, Mojal S, Serrano S, Lorente JA, Lloreta J, Hernández S.
    Hum Pathol; 2012 Oct 24; 43(10):1573-82. PubMed ID: 22417847
    [Abstract] [Full Text] [Related]

  • 13. Response of head and neck squamous cell carcinoma cells carrying PIK3CA mutations to selected targeted therapies.
    Wirtz ED, Hoshino D, Maldonado AT, Tyson DR, Weaver AM.
    JAMA Otolaryngol Head Neck Surg; 2015 Jun 24; 141(6):543-9. PubMed ID: 25855885
    [Abstract] [Full Text] [Related]

  • 14. Identification of KRAS and PIK3CA but not BRAF mutations in patients with gastric cancer.
    Lu W, Wei H, Li M, Wang H, Liu L, Zhang Q, Liu L, Lu S.
    Mol Med Rep; 2015 Jul 24; 12(1):1219-24. PubMed ID: 25815786
    [Abstract] [Full Text] [Related]

  • 15. Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma.
    Baba Y, Maeda T, Suzuki A, Takada S, Fujii M, Kato Y.
    Int J Mol Sci; 2017 Jan 26; 18(2):. PubMed ID: 28134774
    [Abstract] [Full Text] [Related]

  • 16. The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.
    Therkildsen C, Bergmann TK, Henrichsen-Schnack T, Ladelund S, Nilbert M.
    Acta Oncol; 2014 Jul 26; 53(7):852-64. PubMed ID: 24666267
    [Abstract] [Full Text] [Related]

  • 17. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH, de Leng WW, de Bree R, van Es RJ, Willems SM.
    Oncotarget; 2016 Sep 20; 7(38):61575-61586. PubMed ID: 27528217
    [Abstract] [Full Text] [Related]

  • 18. [Detection of KRAS, BRAF, PIK3CA and EGFR gene mutations in colorectal carcinoma].
    Ling Y, Ying JM, Qiu T, Shan L, Guo L, Lü N.
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep 20; 41(9):590-4. PubMed ID: 23157825
    [Abstract] [Full Text] [Related]

  • 19. KRAS, BRAF and PIK3CA mutations in human colorectal cancer: relationship with metastatic colorectal cancer.
    Li HT, Lu YY, An YX, Wang X, Zhao QC.
    Oncol Rep; 2011 Jun 20; 25(6):1691-7. PubMed ID: 21424126
    [Abstract] [Full Text] [Related]

  • 20. Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma.
    Al-Amri AM, Vatte C, Cyrus C, Chathoth S, Hashim TM, Mohamed YS, Al Ali R, Alsaid A, Al Ali A.
    Cancer Biomark; 2016 Jun 20; 16(3):377-83. PubMed ID: 26889984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.